|
|
FOR IMMEDIATE RELEASE August 11, 2004. Guava Technologies Inc., has announced the appointment of David A. King, Ph.D., to the position of vice president, Product Development. Guava Technologies further strengthens product development .. Guava Technologies Inc., has announced the appointment of David A. King, Ph.D., to the position of vice president, Product Development. Dr. King was previously head of New Product Development and Product Integration, reporting to the CEO, of iolon a privately-held venture-backed San Jose, California-based manufacturer of tunable optical components. "David has an impressive track record generating ideas for optically-based systems in both Life Sciences and Telecommunications, and driving these ideas through technology development, product design, prototyping and manufacturing," said Rajen Dalal, president and CEO of Guava Technologies. "He has the ability to build and lead interdisciplinary teams and focus them quickly to commercialise cost effective products." Prior to joining iolon, Dr. King was principle engineer at Palo Alto, California-based Agilent Technologies where he developed in-vitro diagnostic testing instrument systems for use in clinical settings. Previously he was a key member of the technical staff at Hewlett Packard where he worked on medical devices and nucleic acid array technologies. "Guava is combining new micro-fluidic, optical, software, and fluorescent technologies to develop products that simplify cellular analysis," said Dr. King. "I am excited to join a team that has a strong track record for delivering solutions that enable our customers to be more productive. The value Guava adds for customers will have a significant impact in both the life sciences and clinical markets world-wide." Dr. King received his M.S. and Ph.D. in Applied Physics from Stanford University, where he was a Fulbright Scholar. He has authored 20 patents and published 15 papers in physics, physical chemistry, and life science. Guava Technologies, Inc. is a California-based venture-backed biotechnology and medical device company. Guava's product offerings combine rugged and reliable instrument platforms with a variety of assays and software modules to provide complete solutions for easy-to-use on-demand cellular analysis. Guava's instrument platforms, the Personal Cell Analyser (PCA), PCA-96, and Easycyte, are designed to be flexible, highly affordable, and ultra-compact. Guava's unique technology enables analysis of micro liter sample volumes with embedded absolute cell counting and identification. Guava's products have broad applications in scientific research, throughout the drug discovery and lead optimisation process, and optimisation of commercial bio-pharmaceutical production. Guava's technology also offers potential for use in medically related areas where cellular analysis is critical such as clinical diagnostics, clinical trials and blood safety.
CONTACTS:
|
Home | News | CombiChem | CombiChem Links | HTS | Lab Automation
Sales | Email Us | Repairs | Disclaimer | © 1999-2004